Delivery Order SPE2DB22D3004-SPE2DB25FQB03

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,357.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a medication used to treat migraine headaches. The delivery order has a period of performance through June 26, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,202.87 firm-fixed-price delivery order is for SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a medical product used to treat migraines. The award has an ultimate completion date of April 8, 2025. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,491.82, is for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a medical product used for treating migraines. The contract is a firm fixed-price delivery order with a period of performance through March 2025. No set-aside designation was used. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,266.97, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a migraine medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $2,722.04 and covers the delivery of 4563651921 - SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of February 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the supply of 4566545777 SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a migraine medication, with a ceiling value of $27,781.10 and a performance period through November 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,346.11, is for the delivery of 4564794080 - SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialty medication. The contract is a firm fixed-price delivery order with a completion date of June 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a migraine medication, with a ceiling value of $2,597.96 and a period of performance through April 9, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML. The contract has a ceiling value of $3,007.89 and a period of performance ending on March 25, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and sole awardee. This delivery order is...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,538.22, is for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialized pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQB03
    Delivery Order

This is a $2,972.80 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialty migraine medication. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 8:44 AM